Chemical Compound Review:
AGN-PC-00HO7L (17-ethanoyl-6,10,13- trimethyl-3-oxo-2,8,9...
Synonyms:
SureCN5021332, AC1L1HAP, AR-1H2191, AC1Q6OH3, LT00244865, ...
- Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor. Goss, P.E. Breast Cancer Res. Treat. (1998)
- Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial. Yeh, S.S., Hafner, A., Chang, C.K., Levine, D.M., Parker, T.S., Schuster, M.W. Journal of the American Geriatrics Society. (2004)
- A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases. Howell, A., Robertson, J.F., Vergote, I. Breast Cancer Res. Treat. (2003)
- Progestins in breast cancer treatment. A review. Lundgren, S. Acta oncologica (Stockholm, Sweden) (1992)
- Supportive treatment in weight-losing cancer patients due to the additive adverse effects of radiation treatment and/or chemotherapy. Erkurt, E., Erkisi, M., Tunali, C. J. Exp. Clin. Cancer Res. (2000)
- The role of progestins in the treatment of breast cancer. Blumenschein, G.R. Semin. Oncol. (1983)
- Aromatase inhibitors. Cunnick, G.H., Mokbel, K. Current medical research and opinion. (2001)
- The influence of progestins on receptor levels in breast cancer metastasis. Lundgren, S., Kvinnsland, S., Varhaug, J.E., Utaaker, E. Anticancer Res. (1987)
- Hormonal modulation of Ishikawa cells during three-dimensional growth in vitro. Pinelli, D.M., Drake, J., Williams, M.C., Cavanagh, D., Becker, J.L. J. Soc. Gynecol. Investig. (1998)